Yttrium-90 Transarterial Radioembolization of Primary Lung Cancer Metastases to the Liver.

ABSTRACT:

Purpose

To assess whether yttrium-90 transarterial radioembolization (TARE) is safe and effective in the treatment of primary lung cancer metastases to the liver (LCML).

Methods and methods

This retrospective study included 57 patients with LCML who were treated with 79 TARE treatments. Histology included non-small cell lung cancer (NSCLC) (n = 27), small cell lung cancer (SCLC) (n = 17), and lung carcinoid (LC) (n = 13). Survival was calculated using Kaplan-Meier method; differences between groups were estimated using log rank test. Cox proportional hazards model was used to determine factors influencing survival. Adverse events were graded using the Society of Interventional Radiology Adverse Events Classification.

Results

Median overall survival (OS) was as follows

SUBMITTER: Alexander ES 

PROVIDER: S-EPMC11323230 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature